These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28642144)

  • 21. [The value of real-time PCR analysis of serum samples for early diagnosis of invasive pulmonary aspergillosis in organ transplant recipients].
    Zhu XM; Zhou X
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Sep; 31(9):678-81. PubMed ID: 19080569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchogenic carcinoma and secondary aspergillosis--common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis.
    Shahid M; Malik A; Bhargava R
    Cancer; 2008 Aug; 113(3):547-58. PubMed ID: 18521930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Aspergillus species in bone marrow transplant patients.
    Badiee P; Alborzi A
    J Infect Dev Ctries; 2010 Sep; 4(8):511-6. PubMed ID: 20818103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.
    Florent M; Katsahian S; Vekhoff A; Levy V; Rio B; Marie JP; Bouvet A; Cornet M
    J Infect Dis; 2006 Mar; 193(5):741-7. PubMed ID: 16453271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Aspergillus-specific PCR as a screening method for invasive aspergillosis in paediatric cancer patients and allogeneic haematopoietic stem cell recipients with suspected infections.
    Reinwald M; Konietzka CA; Kolve H; Uhlenbrock S; Ahlke E; Hummel M; Spiess B; Hofmann WK; Buchheidt D; Groll AH
    Mycoses; 2014 Sep; 57(9):537-43. PubMed ID: 24655146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
    Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
    J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad trial.
    Hummel M; Spiess B; Cornely OA; Dittmer M; Mörz H; Buchheidt D
    Eur J Haematol; 2010 Aug; 85(2):164-9. PubMed ID: 20374275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.
    Halliday C; Hoile R; Sorrell T; James G; Yadav S; Shaw P; Bleakley M; Bradstock K; Chen S
    Br J Haematol; 2006 Feb; 132(4):478-86. PubMed ID: 16412020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective Biomarker Screening for Diagnosis of Invasive Aspergillosis in High-Risk Pediatric Patients.
    Loeffler J; Hafner J; Mengoli C; Wirth C; Heussel CP; Löffler C; White PL; Ullmann AJ; Michel D; Wiegering V; Wölfl M; Schlegel PG; Einsele H; Springer J; Eyrich M
    J Clin Microbiol; 2017 Jan; 55(1):101-109. PubMed ID: 27795339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular detection of invasive aspergillosis in hematologic malignancies.
    Badiee P; Kordbacheh P; Alborzi A; Ramzi M; Shakiba E
    Infection; 2008 Dec; 36(6):580-4. PubMed ID: 18854937
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Imbert S; Meyer I; Palous M; Brossas JY; Uzunov M; Touafek F; Gay F; Trosini-Desert V; Fekkar A
    Front Microbiol; 2018; 9():1877. PubMed ID: 30154779
    [No Abstract]   [Full Text] [Related]  

  • 33. PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis.
    Chong GM; van der Beek MT; von dem Borne PA; Boelens J; Steel E; Kampinga GA; Span LF; Lagrou K; Maertens JA; Dingemans GJ; Gaajetaan GR; van Tegelen DW; Cornelissen JJ; Vonk AG; Rijnders BJ
    J Antimicrob Chemother; 2016 Dec; 71(12):3528-3535. PubMed ID: 27530755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
    Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
    Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies.
    Rogers TR; Morton CO; Springer J; Conneally E; Heinz W; Kenny C; Frost S; Einsele H; Loeffler J
    Br J Haematol; 2013 May; 161(4):517-24. PubMed ID: 23614624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspergillus antigen and PCR assays in bone marrow transplanted children.
    Bialek R; Moshous D; Casanova JL; Blanche S; Hennequin C
    Eur J Med Res; 2002 Apr; 7(4):177-80. PubMed ID: 12010653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galactomannan and Polymerase Chain Reaction-Based Screening for Invasive Aspergillosis Among High-Risk Hematology Patients: A Diagnostic Meta-analysis.
    Arvanitis M; Anagnostou T; Mylonakis E
    Clin Infect Dis; 2015 Oct; 61(8):1263-72. PubMed ID: 26157047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Commercially Available Real-Time Polymerase Chain Reaction Assays for the Diagnosis of Invasive Aspergillosis in Patients with Haematological Malignancies.
    Erman-Daloglu A; Ozhak B; Salim O; Turhan O; Ongut G; Gunseren F; Colak D; Ogunc D
    Mycopathologia; 2020 Apr; 185(2):269-277. PubMed ID: 31950340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients.
    Herbrecht R; Letscher-Bru V; Oprea C; Lioure B; Waller J; Campos F; Villard O; Liu KL; Natarajan-Amé S; Lutz P; Dufour P; Bergerat JP; Candolfi E
    J Clin Oncol; 2002 Apr; 20(7):1898-906. PubMed ID: 11919250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative performance of Aspergillus galactomannan ELISA and PCR in sputum from patients with ABPA and CPA.
    Fayemiwo S; Moore CB; Foden P; Denning DW; Richardson MD
    J Microbiol Methods; 2017 Sep; 140():32-39. PubMed ID: 28645480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.